A Phase I/II Study to Evaluate the Toxicity and Efficacy of Accelerated Fractionation Radiotherapy for the Palliation of Dysphagia from Carcinoma of the Oesophagus

Clinical Oncology

Volumn 20, Issue 1, 2008, Pages 53-60

  Kassam, Z ^a   Wong, R K S ^a   Ringash, J ^a   Ung, Y ^b   Kamra, J ^b   DeBoer, G ^b   O'Brien, M ^b   Kim, J ^a   Loblaw, D A ^b   Wong, S ^b   Cummings, B ^a   Davey, P ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Accelerated fractionation; dysphagia; oesophageal carcinoma; quality of life; radiotherapy

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ANOREXIA; ARTICLE; BARIUM ENEMA; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FLUOROSCOPY; HEARTBURN; HUMAN; LETHARGY; MALE; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; SURVIVAL TIME; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY OF LIFE; RADIATION INJURIES; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 38149072375     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.10.003     Document Type: Article

References (45)

1. Laing J.H., Rew D.A., and Wilson G.D. Cell kinetics of human solid tumors. Br J Radiol 24 Suppl (1992) 163-167
2. Fowler J.F., Harari P.M., Lebourgne F., et al. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
3. Denham J.W., Walker Q.J., Lamb D.S., et al. Mucosal regeneration during radiotherapy. Radiother Oncol 41 (1996) 109-118
4. O'Rourke I.C., Tiver K., Bull C., et al. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer 61 (1988) 2022-2026
5. Blazeby J.M., Williams M.H., Brookes S.T., et al. Quality of life measurement in patients with oesophageal cancer. Gut 37 (1995) 505-508
6. Blazeby J.M., Conroy T., Hammerlid E., et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39 (2003) 1384-1394
7. Osoba D., Rodrigues G., Myles J., et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1998) 139-144
8. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
9. Mackillop W.J. The principles of palliative radiotherapy: a radiation oncologist's perspective. Can J Oncol 6 Suppl 1 (1996) 5-11
10. Caspers R.J., Welvaart K., Verkes R.J., et al. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol 12 (1988) 15-23
11. Albertsson M., Ewers S.B., Widmark H., et al. Evaluation of the palliative effect of radiotherapy for esophageal carcinoma. Acta Oncol 28 (1989) 267-270
12. Fang F.M., Tsai W.L., Chiu H.C., et al. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 1394-1404
13. Rathi A.K., Bahadur A.K., and Broor S.L. Swallowing performance after radiotherapy for squamous cell carcinoma oesophagus. Trop Gastroenterol 18 (1997) 95-97
14. Cwikiel M., Cwikiel W., and Albertsson M. Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol 35 (1996) 75-79
15. Hayter C.R., Huff-Winters C., Paszat L., et al. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol 56 (2000) 329-333
16. Wara W.M., Mauch P.M., Thomas A.N., et al. Palliation for carcinoma of the esophagus. Radiology 121 (1976) 717-720
17. Elkon D., Lee M.S., and Hendrickson F.R. Carcinoma of the esophagus: sites of recurrence and palliative benefits after definitive radiotherapy. Int J Radiat Oncol Biol Phys 4 (1978) 615-620
18. Agrawal R.K., Dawes P.J., and Clague M.B. Combined external beam and intracavitary radiotherapy in oesophageal carcinoma. Clin Oncol (R Coll Radiol) 4 (1992) 222-227
19. Datta N.R., Kumar S., Nangia S., et al. A non-randomized comparison of two radiotherapy protocols in inoperable squamous cell carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 10 (1998) 306-312
20. Kharadi M.Y., Qadir A., Khan F.A., et al. Comparative evaluation of therapeutic approaches in stage III and IV squamous cell carcinoma of the thoracic esophagus with conventional radiotherapy and endoscopic treatment in combination and endoscopic treatment alone: a randomized prospective trial. Int J Radiat Oncol Biol Phys 39 (1997) 309-320
21. Levine M.S., Langer J., Laufer I., et al. Radiation therapy of esophageal carcinoma: correlation of clinical and radiographic findings. Gastrointest Radiol 12 (1987) 99-105
22. Leborgne R., Leborgne F., and Barlocci L. Cancer of the oesophagus. Results of radiotherapy. Br J Radiol 36 (1963) 806-811
23. Marcial V.A., Tome J.M., Ubinas J., et al. The role of radiation therapy in esophageal cancer. Radiology 87 (1966) 231-239
24. Lewinsky B.S., Annes G.P., Mann S.G., et al. Carcinoma of the esophagus: an analysis of results and of treatment techniques. Radiol Clin (Basel) 44 (1975) 192-204
25. Beatty J.D., DeBoer G., and Rider W.D. Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 43 (1979) 2254-2267
26. Slevin N.J., and Stout R. Carcinoma of the oesophagus - a review of 108 cases treated by radical radiotherapy. Clin Radiol 40 (1989) 200-203
27. Leslie M.D., Dische S., Saunders M.I., et al. The role of radiotherapy in carcinoma of the thoracic oesophagus: an audit of the Mount Vernon experience 1980-1989. Clin Oncol (R Coll Radiol) 4 (1992) 114-118
28. Peng K.G. Comparison of three different fractionations in radiotherapy for esophageal carcinoma - a prospective randomized trial on 80 patients. Zhonghua Zhong Liu Za Zhi 13 (1991) 232-234
29. Wan J., Guo B.Z., and Gao S.Z. Accelerated hyperfractionation radiotherapy in esophageal cancer. An analysis of 172 cases. Chin Med J (Engl) 104 (1991) 228-229
30. Zhao Y.L., Wei G.Q., and Sha Y.H. A randomized clinical study of preoperative accelerated radiotherapy versus routine radiotherapy for late esophageal cancers - an analysis of 177 cases. Zhonghua Zhong Liu Za Zhi 16 (1994) 444-446
31. Li X., and Xuehui S. Acute toxic effect of accelerated hyperfractionation radiotherapy. Chinese J Clin Oncol 26 (1999) 12-15
32. Shi X.H., Yao W., and Liu T. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 51 (1999) 21-26
33. Gao X.S., Qiao X.Y., Yang X.R., et al. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma. Oncol Rep 9 (2002) 767-772
34. Powell M.E., Hoskin P.J., Saunders M.I., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys 38 (1997) 133-136
35. Harney J., Goodchild K., Phillips H., et al. A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 15 (2003) 109-114
36. Herskovic A., and Al-Sarraf M. Combination of 5-fluorouracil and radiation in esophageal cancer. Semin Radiat Oncol 7 (1997) 283-290
37. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
38. al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15 (1997) 277-284
39. Ask A., Albertsson M., Jarhult J., et al. A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 42 (2003) 462-475
40. Smith T.J., Ryan L.M., Douglass Jr. H.O., et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 269-276
41. Wong R., and Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev (2001) CD002092
42. Wobbes T., Baron B., Paillot B., et al. Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 37 (2001) 470-477
43. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. J Am Med Assoc 281 (1999) 1623-1627
44. Study in advanced oesophagel ca to compare palliation of dysphagia in pts treated with radiotherapy vs chemo-radiotherapy. Available from: http://www.ctg.queensu.ca/trials/gastro-intestinal/default.html http://www.trog.com.au/ [accessed 16.11.2007].
45. Bezjak A., Dixon P., Brundage M., et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC15). Int J Rad Onc Biol Phys 54 3 (2002) 719-728